Dermata Therapeutics Balance Sheet (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Receivables - Accured (Quarter)						0.01M	0.01M	0.01M	790.00	76.00	0.01M
Assets
Current Assets
Cash & Equivalents (Quarter)	0.43M	12.60M	10.80M	8.19M	10.63M	8.07M	6.24M	8.77M	8.44M	6.63M	7.44M	4.73M	4.95M	6.10M	3.16M	9.70M	6.48M	4.70M	7.52M	6.95M
Raw Materials (Quarter)																				0.09M
Inventory (Quarter)																				0.09M
Prepaid Assets (Quarter)	0.71M	1.08M	0.83M	0.85M	0.40M	0.91M	0.70M	0.53M	0.27M	0.69M	0.54M	0.45M	0.29M	0.54M	0.35M	0.21M	0.16M	0.05M	0.34M	0.43M
Current Assets (Quarter)	1.14M	13.69M	11.62M
Non-Current Assets
Long-Term Deferred Tax (Quarter)			1.63M								2.98M				8.02M
Assets (Quarter)	1.14M	13.69M	11.62M	9.04M	11.03M	8.97M	6.94M	9.30M	8.71M	7.32M	7.98M	5.18M	5.24M	6.69M	3.53M	10.01M	6.64M	5.07M	7.86M	7.47M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.88M	0.77M	0.52M	0.66M	0.61M	0.48M	0.50M	0.49M	0.44M	0.47M	0.87M	0.82M	1.33M	0.86M	0.81M	1.40M	0.41M	0.20M	0.46M	0.10M
Payables (Quarter)	0.88M	0.77M	0.52M	0.66M	0.61M	0.48M	0.50M	0.49M	0.44M	0.47M	0.87M	0.82M	1.33M	0.86M	0.81M	1.40M	0.41M	0.20M	0.46M	0.10M
Accumulated Expenses (Quarter)			0.77M				0.43M	0.13M	0.18M	0.33M	0.76M	0.55M	0.59M	1.08M	1.16M	0.96M	0.49M	0.59M	0.98M	0.73M
Other Accumulated Expenses (Quarter)	0.59M	0.43M	1.00M	0.53M	0.76M	1.02M	0.43M	0.71M	0.25M	0.44M	0.76M	0.55M	0.59M	1.08M	0.14M	0.19M	0.09M	0.06M	432.00	0.05M
Short term Debt (Quarter)
Total Current Liabilities (Quarter)	1.64M	1.20M	1.52M
Non-Current Liabilities
Convertible Debt (Quarter)	0.17M
Non-Current Deferred Tax Liability (Quarter)							1.07M				1.51M	0.09M	0.03M	0.02M	2.62M
Other Non-Current Liabilities (Quarter)	0.59M	0.43M	1.00M	0.53M	0.76M	1.02M	0.43M
Total Non-Current Liabilities (Quarter)	1.06M	0.77M	0.52M	0.66M	0.61M	0.48M	0.50M
Total Liabilities (Quarter)	1.64M	1.20M	1.52M	1.19M	1.37M	1.50M	0.92M	1.21M	0.68M	0.92M	1.62M	1.37M	1.92M	1.95M	1.97M	2.70M	1.03M	1.11M	1.64M	1.05M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	-0.51M	12.49M	10.11M	7.85M	9.66M	7.47M	6.02M	8.09M	8.03M	6.41M	6.36M	3.81M	3.32M	4.74M	1.56M	7.30M	5.61M	3.96M	6.22M	6.41M
Liabilities and Shareholders Equity (Quarter)	1.14M	13.69M	11.62M	9.04M	11.03M	8.97M	6.94M	9.30M	8.71M	7.32M	7.98M	5.18M	5.24M	6.69M	3.53M	10.01M	6.64M	5.07M	7.86M	7.47M
Retained Earnings (Quarter)	-31.72M	-33.43M	46.09M	-38.77M	-41.50M	-43.92M	51.61M	55.92M	57.56M	-51.25M	-53.39M	60.33M	-59.35M	-62.52M	67.24M	75.28M	-69.70M	75.33M	-73.23M	81.49M
Preferred Shares (Quarter)	691.00
Treasury Shares (Quarter)	0.40M										8.36M	0.21M	0.03M		5.07M

Research Tools

Datasets

Plans

Developers

Dermata Therapeutics DRMA Balance Sheet (2020-2026)

Research Tools

Datasets

Plans

Developers

Dermata Therapeutics DRMA Balance Sheet (2020-2026)

Create an account

Sign In

Reset Password